Market Closed -
Other stock markets
|
After market 10:54:41 pm | |||
6.66 EUR | +2.78% | 6.655 | -0.08% |
17/04 | OSE: licensing agreement with AbbVie enters into force | CF |
17/04 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.61% | 151M | |
+22.13% | 46.4B | |
-1.60% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.82% | 26.01B | |
-19.60% | 19.52B | |
+29.37% | 12.43B | |
+0.05% | 12.18B | |
-0.71% | 12.13B |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- Transcript : OSE Immunotherapeutics SA - Special Call